
The Insider Secrets to Processa Pharmaceuticals: A Dark Horse in the Race
Processa Pharmaceuticals (NASDAQ:PCSA) is a biotechnology company focused on enhancing existing cancer treatments to improve safety and efficacy. Insiders, including top executives, recently invested $213,411 at an average share price of $0.80, indicating strong confidence in the company. The stock has experienced